Stonehage Fleming (UK)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.15M Sell
24,100
-2,700
-10% -$229K 0.98% 38
2015
Q3
$2.06M Buy
+26,800
New +$2.24M 0.98% 32
2015
Q1
Sell
-22,600
Closed -$1.82M 204
2014
Q4
$1.82M Sell
22,600
-4,800
-18% -$379K 0.9% 57
2014
Q3
$2.05M Sell
27,400
-8,500
-24% -$618K 0.91% 35
2014
Q2
$2.46M Sell
35,900
-8,600
-19% -$585K 0.99% 25
2014
Q1
$3.11M Buy
+44,500
New +$3.09M 1.32% 34

Other funds holding CAH

Stonehage Fleming (UK)'s CAH Position: Q4 2015 in Review

Stonehage Fleming (UK) reduced its Cardinal Health (CAH) stake by 10% in Q4 2015, selling an estimated $229K and leaving 24,100 shares worth $2.15M. The position accounts for 0.98% of the portfolio, ranked #38.

Stonehage Fleming (UK) first reported a position in CAH in Q1 2014 and has held it in 6 quarters since. The position peaked at $3.11M in Q1 2014. 782 funds tracked by Wall St. Rank hold CAH as of Q4 2015.

  • Stonehage Fleming (UK) held 24,100 shares of Cardinal Health worth $2.15M as of Q4 2015.
  • Stonehage Fleming (UK) sold 2,700 Cardinal Health shares in Q4 2015, an estimated $229K.
  • Cardinal Health made up 0.98% of Stonehage Fleming (UK)'s portfolio in Q4 2015, its #38 holding.
  • Stonehage Fleming (UK) first reported a position in Cardinal Health in Q1 2014 and has held it in 6 quarters since.
  • Stonehage Fleming (UK)'s Cardinal Health position peaked at $3.11M in Q1 2014.
  • 782 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2015, filed 11 Oct 2019.